-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOXCEL THERAPEUTICS PRESENTS NEW DATA FROM SERENITY AT-HOME PHASE 3 TRIAL FOR AGITATION ASSOCIATED WITH BIPOLAR DISORDERS OR SCHIZOPHRENIA AT 2026 ASCP ANNUAL MEETING

Reuters·05/28/2026 11:00:01

Please log in to view news